Private Advisor Group LLC reduced its holdings in ARK Genomic Revolution ETF (BATS:ARKG) by 8.9% in the first quarter, according to its recent filing with the Securities and Exchange Commission (SEC). The fund sold 4,681 shares, leaving it with 48,186 shares valued at $1,386,000. Other hedge funds have also made moves with BNP Paribas Financial Markets increasing its stake by 112.8% and Goldman Sachs Group Inc. by 271.4% in the fourth quarter. ARK Genomic Revolution ETF is currently trading down 0.5% at $23.46. This exchange-traded fund, launched in 2014, is actively managed and focuses on companies in the genomics industry. For more information and insights, stay tuned for MarketBeat.com’s daily email newsletter.